Variance was reported between inratio inr and lab inr results.The results were as follows: on (b)(6) 2016, inratio = 3.2, lab = approximately 4 (1 hour).On (b)(6) 2016, inratio = 1.8, lab = 4.9 (1 hour).The reported therapeutic range: 2.5-3.5 patient had been hospitalized for a severe diabetic infection (date of admittance not provided).After being discharged from the hospital a lab inr=4.9 and later an inratio inr=1.8 performed by the physician.Patient was treated based on the lab results.
|
It is indicated that the product is not returning for evaluation.Therefore, a review of the entire in-house testing history of the lot was performed.In-house strip testing on the reported strip lot meets accuracy criteria.The product performed as expected.The customer's complaint was not replicated.A review of the manufacturing batch records for the reported strip lot12 was performed: the lot met release specifications.The customer was reported to have a severe infection and lung cancer; these conditions may impact the performance of the assay.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|